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Summary 
The ATP-dependent RNA helicase UPF1, a key factor in nonsense-mediated 
mRNA decay (NMD), was so far thought to be recruited specifically to NMD-
targeted mRNAs by aberrantly terminating ribosomes. However, two recent 
publications reporting independently transcriptome-wide mapping of UPF1 
occupancy on RNA challenge this model and instead provide evidence that 
UPF1 binds to mRNA already before translation. According to the new data, 
UPF1 appears to initially bind all mRNAs along their entire length and gets 
subsequently stripped off the coding sequence by translating ribosomes. This 
re-poses the question of where and how UPF1 engages with mRNA and how 
the NMD-targeted transcripts are selected among the UPF1-bound mRNAs.      
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Nonsense-mediated mRNA decay 
During their entire lifespan, mRNAs are accompanied by a changing set of proteins 
and small non-coding (nc)RNAs forming complex messenger riboncleoprotein 
particles (mRNPs) 1. The components of an mRNP and their positioning on the 
mRNA to a large extent determine the fate of the mRNA molecule and hence play 
important roles in the regulation of gene expression. Cells possess multiple 
surveillance mechanisms that detect aberrant mRNPs and promote the degradation 
of the concerned mRNA. Arguably the best-studied surveillance mechanism is 
nonsense-mediated mRNA decay (NMD), which was discovered more than 30 years 
ago and initially described as a translation-dependent process that selectively 
degrades mRNAs with truncated open reading frames (ORFs) due to premature 
translation-termination codons (PTC) 2, 3, thereby preventing the expression of 
potentially deleterious C-terminally truncated proteins. In humans, one out of three 
disease-associated mutations leads to the production of PTC-containing mRNA and 
NMD therefore influences the severity of the clinical manifestations caused by these 
mutations 4-6. Besides its quality control function, genome-wide mRNA profiling 
experiments revealed that NMD also regulates the abundance of many physiological 
mRNAs coding for functional proteins (reviewed in 7).  
 
Unraveling UPF1 functions – the key to understand NMD 
In spite of intensive research over the past decades, our understanding of the 
molecular mechanism of NMD is still fragmentary. Among the so far identified 
proteins involved in NMD, UPF1 plays a – if not the – key role: with 48.5% amino 
acid identity between human and baker’s yeast it is the most conserved NMD factor 
8, it is essential in vertebrates and flies 9-11, and binds RNA unlike most other NMD 
factors. With an estimated 3*106 molecules per cell, UPF1 is a quite abundant protein 
12. In relation to the approx. 3*105 mRNA molecules per cell 13, there are on average 
about 10 UPF1 proteins available per mRNA, which is comparable to the approx. 20 
molecules of poly(A) binding protein (PABP) per mRNA 14. 
 
UPF1 is an ATP-dependent 5’-3’ RNA helicase belonging to the superfamily 1 (SF1) 
15. Two RecA-like domains form the helicase domain with the ATP-binding pocket 
located in between 16. The helicase and the ATPase activities of UPF1 are repressed 
by an N-terminal cysteine/histidine-rich zinc finger (CH) domain and a C-terminal 
domain rich in serine-glutamine motifs (SQ domain) 17-19. Since UPF1’s ATPase 
activity is required for NMD, the inhibitory configurations of the flanking CH and SQ 
domains must be relieved at some point during the NMD process. While the inhibitory 
effect of the CH domain is suspended by its interaction with UPF2, which pulls the 
CH domain from the Rec2A subdomain to the Rec1A subdomain on the opposite 
side of the helicase core 17, it is currently unknown how the SQ domain-mediated 
inhibition is overcome 19. There is evidence that the ATPase activity of UPF1 is 
required for disassembling the NMD complex after the endonucleolytic cleavage of 
the target mRNA, since UPF1 mutants unable to bind or hydrolyze ATP led to the 
accumulation of 3’ RNA decay intermediates 20. As expected for a helicase, UPF1 
has the capacity to unwind RNA duplexes in vitro, an activity that is promoted by the 
other two conserved NMD factors UPF2 and UPF3B 18, but it remains to be seen if 
UPF1 also translocates on RNA in vivo. 
In metazoans, UPF1 is a phosphoprotein with more than a dozen serine or threonine 
followed by glutamine (S/TQ) motifs, and half of them can be phosphorylated in vitro 
by the phosphatidylinositol 3-kinase-related protein kinase SMG1. In vivo, UPF1 
undergoes a cycle of phosphorylation and dephosphorylation, which is essential for 
NMD in metazoans (reviewed in 21). The exact function of UPF1 phosphorylation 
during NMD and its relation to ATP binding and hydrolysis is not known, but the 
endonuclease SMG6 and the decay factor-adaptors SMG5/SMG7 and PNRC2 
preferentially interact with phosphorylated UPF1 and ATPase-deficient UPF1 
mutants accumulate in a hyper-phosphorylated state 22, 23, 24. Recently, Yamashita 
and colleagues identified phospho-T28 and phospho-S1096 to be required for the 
interaction of UPF1 with SMG6 and SMG7, respectively 25.  
 
Current model: selective and translation-dependent recruitment of UPF1 to 
NMD-targeted mRNAs 
A central unsolved question is how the NMD pathway selects its target mRNAs. 
Based on a wealth of biochemical and genetic data, including the above-mentioned 
characteristics of UPF1, the following working model has emerged during the last 
years: in a nutshell, NMD ensues on mRNAs with termination codons in an 
environment unfavorable for efficient translation termination 7, 26. The underlying 
assumption is that the translation termination is a highly regulated process involving 
the orchestrated function of many factors, comparable to translation initiation, and 
that in the absence of a termination promoting factor, ribosomes stall at the 
termination codon 27, 28 and lead to the assembly of NMD factors that ultimately 
degrade the mRNA. Supporting this model, UPF1 was found to interact with the 
release factors eRF1 and eRF3 23, 29, 30 and this interaction is antagonized by the 
interaction between eRF3 and poly(A) binding protein C1 (PABPC1) 31. PABPC1 and 
its yeast homologue Pab1p have been shown to stimulate termination 32, 33, 34 and 
tethering of PABPC1/Pab1p near NMD-triggering termination codons efficiently 
suppresses NMD 27, 31, 34-36. This model provides an explanation why not only PTCs 
but also long 3’ UTRs can elicit NMD 36-38. The detection of an immunoprecipitable 
complex consisting of SMG1, UPF1, eRF1 and eRF3 (called SURF complex 23) 
suggested that SURF might form at ribosomes that fail to terminate properly. 
According to this model, UPF1 would be recruited in a translation-dependent manner 
and only to NMD-targeted transcripts. This view was corroborated by studies 
reporting preferential association of UPF1 with PTC-containing transcripts in C. 
elegans 39 and in human cells 40.  
In the SURF complex, SMG1 kinase is kept in an inactive state by two regulatory 
proteins, SMG8 and SMG9, until UPF2 interacts with UPF1 41. The conformational 
change induced by UPF2 leads to the dissociation of SMG8 and SMG9 and UPF1 
phosphorylation by the activated SMG1 kinase 41, 25. As already mentioned above, 
UPF1 phosphorylation is then thought to commit the mRNA to degradation by the 
recruitment of the decay promoting factors SMG6, SMG5/SMG7 and PNRC2 
(reviewed in 7). 
In the case of exon junction complex (EJC)-independent NMD, free UPF2 would 
have to join the SURF complex by diffusion, which is expected to be a rate-limiting 
step and results in rather inefficient NMD 37, 42. In contrast, classical NMD-targeted 
mRNAs harbor an NMD-enhancing EJC downstream of the termination codon. The 
tetrameric EJC core consisting of eIF4AIII, MAGO, MLN51 and Y14 binds to UPF3, 
which in turn recruits UPF2 43, 44, 45, 46. EJCs assemble at exon-exon junctions during 
splicing 47, 48, 49, 50 and are displaced from the coding sequence during translation by 
the scanning ribosomes 51, 52, so that after onset of translation most mRNAs will be 
devoid of EJCs. However, if the termination codon is located more than 30 
nucleotides upstream of the 3’-most EJC, which often is the case for PTCs, these 
EJCs remain bound to the mRNA and enhance NMD by providing pre-bound UPF2 
ready to interact with the SURF complex (reviewed in 7).  
 Evidence for translation-independent mRNA interaction of UPF1 
The recent development of CLIP-seq (crosslinking and immunoprecipitation followed 
by high-throughput sequencing) techniques allows the transcriptome-wide detection 
of the binding sites for RNA-binding proteins 53, 54. To explore how NMD shapes the 
embryonic transcriptome, Hurt and colleagues performed integrated genome-wide 
analyses of UPF1 binding locations, NMD-regulated gene expression, and translation 
in murine embryonic stem cells (mESCs) 55, and we used CLIP-seq to map the RNA-
binding sites of UPF1 in human cells 56. In both cell types, UPF1 was detected 
predominantly in 3’ UTR sequences, where it was quite evenly distributed, whereas 
coding sequence (CDS) was much less covered with UPF1. This high enrichment of 
UPF1 in 3’ UTRs is consistent with a study from Hogg and Goff, who investigated 
UPF1 association with PP7-tagged reporter transcripts and found that the amount of 
UPF1 interacting with the transcripts correlated with their 3’ UTR length 57. 
Intriguingly and contradicting the above-described NMD model, Hogg and Goff 
further reported that the UPF1 interaction with the tested 3’ UTRs occurred even in 
the absence of translation. To explore this discrepancy, both CLIP-seq studies also 
analyzed RNA binding of UPF1 in translation-suppressed HeLa cells 56 and mESCs 
55, respectively. Translation inhibition unveiled a striking redistribution of UPF1 
towards CDS 55, 56, indicating that before translation UPF1 interacts with mRNAs 
along its entire length and that during translation elongating ribosomes displace it 
from the CDS (Figure 1). Displacement of UPF1 from RNA by elongating ribosomes 
is consistent with results from Hogg and Goff, who showed that even a low frequency 
of translational read-through induced by retroviral RNA elements preceding the stop 
codon reduced the UPF1 association with long 3’ UTRs and stabilized the otherwise 
NMD-targeted reporter transcripts 57. Since CLIP yields relative data, i.e. enrichment 
of sequence x in the IP relative to its abundance in the transcriptome, the shift of 
UPF1 occupancy from 3’ UTR to CDS upon translation inhibition could result from an 
increased binding to CDS, a decreased binding to 3’ UTRs or a combination of both. 
To distinguish between these possibilities, we performed RNA-immunoprecipitations 
(RIP) in which CDS and 3’ UTR of selected endogenous mRNAs were separated by 
an oligo-mediated RNase H cleavage during the IP 56. This assay confirmed the 
marked increase of UPF1 association with CDS upon translation inhibition, 
corroborating the conclusion that UPF1 binds to CDS in the absence of translation 
and gets displaced from CDS during translation. 
Furthermore, association of UPF1 with long ncRNAs was also detected, providing 
additional evidence for translation-independent binding 56. As expected for 
untranslated RNA, the UPF1 binding on these transcripts was not altered by 
translation inhibition.   
  
Specificity of UPF1 for mRNA 
What do the two CLIP papers tell us about the specificity of the UPF1-RNA 
interaction? As one might have expected for a helicase, motif searches did not reveal 
any preferred RNA binding sequence for UPF1. Nevertheless, UPF1 was clearly 
distributed along RNA in a non-random fashion. Hurt and colleagues found an 
enriched UPF1 density in G-rich areas with an increased propensity to form 
secondary structures 55. Our analysis did not reveal any sequence preference except 
for a bias towards U at the position of the crosslink 56, which most likely just reflects 
the better UV crosslinking efficiency of U compared to the other bases 58. 
Interestingly with regards to the question of when and how UPF1 is recruited to RNA, 
UPF1 density was 10 – 30-fold higher in exons than introns in both studies, and also 
very little UPF1 association was detected with rRNA and tRNA. This suggests that 
UPF1 associates with mRNA during or after splicing. UPF1 recruitment to mRNA 
during splicing together with the EJC seemed to be an attractive hypothesis at first 
glance, because UPF1 interacts with the EJC through UPF2 and UPF3 46, but both 
CLIP studies did find no correlation between UPF1 binding and EJC deposition. Hurt 
and colleagues showed that genes encoding for transcripts with high UPF1 binding 
density in their 3’ UTR were not enriched for the expression of downstream EJC-
containing isoforms 55, and we did not find any correlation between the UPF1 and the 
recently reported EJC binding sites 56, 59. Moreover, knockdown of the EJC core 
factor eIF4AIII did not affect UPF1 association with mRNA 60. Thus, the available 
data indicates that UPF1 engages with mRNA independently of EJCs and the 
specificity of UPF1 for mRNA remains to be explored in the future. It is conceivable 
that UPF1 binds RNA in the cytoplasm and that mRNA specificity results from the 
fact that the highly structured tRNAs and the rRNAs, which assemble through a 
highly orchestrated process into ribosomal subunits, are simply not accessible for 
UPF1 binding. 
 If not UPF1 binding, what is the distinctive step in NMD target selection? 
According to the above-described NMD model, UPF1 recruitment to an mRNA marks 
this mRNA for NMD and UPF1 should therefore preferentially – if not exclusively – be 
associated with NMD targeted mRNAs. Consistent with this model, a recent study 
conducted with a set of reporter transcripts reported the accumulation of more UPF1 
molecules per 3’ UTR length unit if the mRNA was an NMD target 40. However, the 
transcriptome-wide analyses gave a more complex picture: the results of Hurt and 
colleagues indicate a correlation between UPF1 binding and NMD only for transcripts 
with short 3’ UTRs, most of which harbor an EJC as the NMD-inducing signal 55. 
However, no significant difference in UPF1 density was detected when we compared 
two sets of experimentally identified endogenous NMD targets 38, 61 with 
corresponding control groups of transcripts that are not affected by NMD 56. 
The lack of a strict correlation between UPF1 binding and NMD together with the 
evidence for translation-independent binding of UPF1 to mRNA challenges the idea 
that UPF1 binding would be the step that commits an mRNA to the NMD pathway. At 
the same time, it re-opens the question about what the NMD-triggering step then 
would be. At this moment, one can only speculate and more research is clearly 
needed. An obvious possibility is that the SMG1-mediated phosphorylation of UPF1, 
which leads to recruitment of RNA degradation factors (see above), represents the 
activation step of NMD that specifically occurs when ribosomes fail to properly 
terminate translation (Figure 1). A variation of the same theme is that UPF1 
indiscriminately binds to mRNA and acts there like a ticking bomb: if not stripped off 
by ribosomes within a certain time window, it will become phosphorylated and induce 
the decay of the mRNA. Both scenarios predict that hyper-phosphorylated UPF1 
would be found associated specifically with NMD targeted transcripts, a prediction 
that can be tested by purification of affinity-tagged reporter transcripts. It could also 
be that ATP binding or hydrolysis by UPF1 are the crucial steps to activate NMD.  
 
Crosslink sites do not necessarily represent the locations of initial binding 
Another open question is whether UPF1 initially engages with mRNA at specific sites. 
The crosslinking sites detected in the two CLIP studies do not necessarily represent 
the positions of initial UPF1 binding to mRNA, because UPF1 can probably 
translocate on RNA by virtue of its 5’-to-3’ helicase activity. An interesting follow-up 
study would therefore be to CLIP exogenously expressed tagged UPF1 mutants 
defective in ATP binding, ATP hydrolysis and/or helicase activity. 
 
UPF1 reveals its secrets only slowly  
While it is obvious to all researchers in the field that understanding UPF1 function is 
key to understand NMD, this protein does not divulge its secrets easily. Our current 
understanding can be summarized by the following statement by J.R. Hogg: “…UPF1 
accumulation in mRNPs is a prerequisite for decay but is not sufficient to consign the 
mRNP to destruction. Instead the initiation of decay requires the completion of one or 
more additional rate-limiting steps…” 62. Additional investigations of the activities, 
regulation and interactions of UPF1 and other NMD proteins in the context of 
endogenous mRNPs are needed to reveal the order of events leading from UPF1 
accumulation in mRNPs to the decay of the mRNAs.  
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Figure legend 
 
Figure 1. Modified working model for NMD based on the new evidence for UPF1 
interaction with mRNA before translation. The coding sequence (CDS), starting with 
AUG and ending with a stop codon (UGA in this Figure), is depicted by a light grey 
box. UPF1 (orange ovals) associates along the entire mRNA during or after splicing, 
but before translation starts. The ribosome (red) then displaces UPF1 from the CDS. 
It is not known whether displaced UPF1 can rebind in the UTR regions (indicated by 
the question mark). According to the model, the kinetics of translation termination 
determines if NMD ensues. Proper termination is typified by a short residence time of 
the ribosme at the stop codon (bottom left), while the absence of termination 
promoting signals (e.g. PABPC1) stalls the ribosome at the stop codon, allowing 
remaining UPF1 to interact with the release factors (eRFs, light blue) and the SMG1 
complex (yellow; bottom right). Interaction of UPF2 (light green) with the 
UPF1:SMG1:eRFs (SURF) complex induces a conformational change that leads to 
dissociation of SMG8 and SMG9 and to the activation of SMG1’s kinase activity. 
Phosphorylated UPF1 subsequently recruits directly (SMG6) and/or indirectly 
(SMG5/SMG7) RNA decay factors, leading to the degradation of the mRNA. 
 
SMG1
UPF1
SMG8
SMG9
UPF2
UGA
Proper termination NMD
Ribosome
stalling time
UGAAUG
?
AUG UGA
AUG
